Pegcantratinib Uses, Dosage, Side Effects and more
Pegcantratinib is under investigation in clinical trial NCT03448081 (Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene).
| Trade Name | Pegcantratinib |
| Generic | Pegcantratinib |
| Pegcantratinib Other Names | Pegcantratinib |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
